11/29
04:21 pm
idxx
IDEXX Laboratories (IDXX): A Fresh Look at Valuation After Recent Momentum Shift [Yahoo! Finance]
Medium
Report
IDEXX Laboratories (IDXX): A Fresh Look at Valuation After Recent Momentum Shift [Yahoo! Finance]
11/29
03:35 am
idxx
IDEXX Laboratories (NASDAQ:IDXX) was downgraded by analysts at
Wall Stre
Medium
Report
IDEXX Laboratories (NASDAQ:IDXX) was downgraded by analysts at
Wall Stre
11/28
07:05 pm
idxx
Idexx (IDXX) Upgraded to Buy: Here's What You Should Know [Yahoo! Finance]
Medium
Report
Idexx (IDXX) Upgraded to Buy: Here's What You Should Know [Yahoo! Finance]
11/26
02:09 pm
idxx
IDEXX Laboratories (NASDAQ:IDXX) had its "hold (c+)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
IDEXX Laboratories (NASDAQ:IDXX) had its "hold (c+)" rating reaffirmed by analysts at
Weiss Ratings.
11/20
05:22 pm
idxx
How the Story Around IDEXX Is Shifting With Strong Results and New Analyst Targets [Yahoo! Finance]
Medium
Report
How the Story Around IDEXX Is Shifting With Strong Results and New Analyst Targets [Yahoo! Finance]
11/16
01:09 am
idxx
IDEXX Laboratories (NASDAQ:IDXX) was upgraded by analysts at
Wall Street
Medium
Report
IDEXX Laboratories (NASDAQ:IDXX) was upgraded by analysts at
Wall Street
11/11
07:00 am
idxx
Demeetra AgBio's CleanCut GS CHO Cells Achieve Dual Viral Clearance Validation, Confirming GMP-Ready Status
Low
Report
Demeetra AgBio's CleanCut GS CHO Cells Achieve Dual Viral Clearance Validation, Confirming GMP-Ready Status
11/6
08:11 pm
idxx
Why IDEXX Laboratories (IDXX) Is Up 13.6% After Strong Q3 Results and Raised 2025 Guidance [Yahoo! Finance]
Low
Report
Why IDEXX Laboratories (IDXX) Is Up 13.6% After Strong Q3 Results and Raised 2025 Guidance [Yahoo! Finance]
11/4
12:08 pm
idxx
IDEXX Laboratories (NASDAQ:IDXX) was given a new $805.00 price target on by analysts at Morgan Stanley. They now have an "overweight" rating on the stock.
Low
Report
IDEXX Laboratories (NASDAQ:IDXX) was given a new $805.00 price target on by analysts at Morgan Stanley. They now have an "overweight" rating on the stock.
11/4
10:28 am
idxx
IDEXX Laboratories (NASDAQ:IDXX) had its price target raised by analysts at JPMorgan Chase & Co. from $675.00 to $775.00. They now have an "overweight" rating on the stock.
Low
Report
IDEXX Laboratories (NASDAQ:IDXX) had its price target raised by analysts at JPMorgan Chase & Co. from $675.00 to $775.00. They now have an "overweight" rating on the stock.
11/4
08:43 am
idxx
IDEXX Laboratories (NASDAQ:IDXX) was given a new $750.00 price target on by analysts at UBS Group AG. They now have a "neutral" rating on the stock.
Low
Report
IDEXX Laboratories (NASDAQ:IDXX) was given a new $750.00 price target on by analysts at UBS Group AG. They now have a "neutral" rating on the stock.
11/4
08:05 am
idxx
IDEXX Laboratories (NASDAQ:IDXX) was given a new $830.00 price target on by analysts at BTIG Research.
Low
Report
IDEXX Laboratories (NASDAQ:IDXX) was given a new $830.00 price target on by analysts at BTIG Research.
11/4
07:21 am
idxx
IDEXX Laboratories (NASDAQ:IDXX) had its "buy" rating reaffirmed by analysts at Jefferies Financial Group Inc..
Low
Report
IDEXX Laboratories (NASDAQ:IDXX) had its "buy" rating reaffirmed by analysts at Jefferies Financial Group Inc..
11/3
06:10 pm
idxx
IDEXX Laboratories (NASDAQ:IDXX) was given a new $785.00 price target on by analysts at Leerink Partners.
Low
Report
IDEXX Laboratories (NASDAQ:IDXX) was given a new $785.00 price target on by analysts at Leerink Partners.
11/3
06:10 pm
idxx
IDEXX Laboratories (NASDAQ:IDXX) was given a new $775.00 price target on by analysts at Stifel Nicolaus.
Low
Report
IDEXX Laboratories (NASDAQ:IDXX) was given a new $775.00 price target on by analysts at Stifel Nicolaus.
11/3
06:30 am
idxx
IDEXX Laboratories Announces Third Quarter Results
Medium
Report
IDEXX Laboratories Announces Third Quarter Results
10/31
08:06 am
idxx
IDEXX Laboratories (NASDAQ:IDXX) was upgraded by analysts at Stifel Nicolaus from a "hold" rating to a "buy" rating. They now have a $700.00 price target on the stock, up previously from $640.00.
Low
Report
IDEXX Laboratories (NASDAQ:IDXX) was upgraded by analysts at Stifel Nicolaus from a "hold" rating to a "buy" rating. They now have a $700.00 price target on the stock, up previously from $640.00.
10/30
09:32 am
idxx
With EPS Growth And More, IDEXX Laboratories (NASDAQ:IDXX) Makes An Interesting Case [Yahoo! Finance]
Low
Report
With EPS Growth And More, IDEXX Laboratories (NASDAQ:IDXX) Makes An Interesting Case [Yahoo! Finance]
10/22
04:20 am
idxx
Companion Animal Diagnostics Market Size to Reach USD 14.47 Billion by 2034 [Yahoo! Finance]
Low
Report
Companion Animal Diagnostics Market Size to Reach USD 14.47 Billion by 2034 [Yahoo! Finance]
10/16
07:00 am
idxx
Bonsai Health Names ModMed Veteran Rick Trefzger Chief Revenue Officer
Low
Report
Bonsai Health Names ModMed Veteran Rick Trefzger Chief Revenue Officer
10/10
06:38 am
idxx
How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings [Yahoo! Finance]
Low
Report
How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings [Yahoo! Finance]
10/8
11:41 pm
idxx
IDEXX Laboratories (IDXX): Exploring Valuation After Impressive Share Price Momentum [Yahoo! Finance]
Low
Report
IDEXX Laboratories (IDXX): Exploring Valuation After Impressive Share Price Momentum [Yahoo! Finance]
10/8
09:38 pm
idxx
Should Investors Reevaluate IDEXX After Its 54% 2025 Share Price Surge? [Yahoo! Finance]
Low
Report
Should Investors Reevaluate IDEXX After Its 54% 2025 Share Price Surge? [Yahoo! Finance]
10/8
02:40 pm
idxx
IDEXX Laboratories to Release 2025 Third Quarter Financial Results [Yahoo! Finance]
Neutral
Report
IDEXX Laboratories to Release 2025 Third Quarter Financial Results [Yahoo! Finance]
10/8
02:00 pm
idxx
IDEXX Laboratories to Release 2025 Third Quarter Financial Results
Low
Report
IDEXX Laboratories to Release 2025 Third Quarter Financial Results